{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:13:31Z","timestamp":1788952411642,"version":"build-2803163510"},"reference-count":37,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00439160"],"award-info":[{"award-number":["RS-2024-00439160"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1C1C1012962"],"award-info":[{"award-number":["NRF-2021R1C1C1012962"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00398073"],"award-info":[{"award-number":["RS-2024-00398073"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"award":["RS-2024-00439160"],"award-info":[{"award-number":["RS-2024-00439160"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"publisher"}]},{"award":["NRF-2021R1C1C1012962"],"award-info":[{"award-number":["NRF-2021R1C1C1012962"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"publisher"}]},{"award":["RS-2024-00398073"],"award-info":[{"award-number":["RS-2024-00398073"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background\/Objectives: Respiratory pathogens such as influenza virus and SARS-CoV-2 pose major threats to global public health. Current vaccines provide limited mucosal protection against respiratory infection, while vaccine-induced immunity can wane over time. Intranasal vaccination has emerged as a promising approach to induce mucosal immunity, however relatively low immunogenicity and limited durability remain major challenges. Various strategies have therefore been explored to improve intranasal vaccine efficacy, including mucosal adjuvants and alternative vaccine platforms. In this study, we evaluated the magnitude and durability of systemic and mucosal immune responses induced by an adenoviral vector vaccine. Methods: Six-week-old female C57BL\/6 mice were immunized intranasally or intramuscularly with a single dose of an adenoviral vector vaccine and compared with mice receiving one or two doses of an intranasal CpG-adjuvanted protein vaccine. Humoral immune responses in serum and BALF, as well as cellular immune responses in the mLNs, lungs, and blood, were evaluated. We further assessed Ova-specific CD8 T cells with a lung-resident phenotype by class I MHC-peptide tetramer staining combined with intravascular labeling, allowing their direct ex vivo identification. Results: A single dose of intranasal adenoviral vector vaccination elicited potent serum IgG and BALF IgA responses, together with antigen-specific CD8 T cell responses in the blood, mLNs, and lungs. Notably, these systemic and respiratory mucosal immune responses were sustained for up to 4 months after vaccination, with lung-resident CD8 T cell responses detected at this time point. In contrast, intramuscular adenoviral vector vaccination predominantly induced systemic immunity. Intranasal CpG-adjuvanted protein vaccination induced weaker responses after a single dose, while booster vaccination enhanced systemic antibody and cellular responses but showed limited induction of mucosal immunity. Conclusions: A single intranasal dose of Ad5-Ova induced systemic and respiratory mucosal immune responses comparable to those observed after two-dose Ova+CpG vaccination, while maintaining these responses for up to 4 months. These findings suggest adenoviral vectors as a promising platform for inducing long-lasting respiratory mucosal immunity.<\/jats:p>","DOI":"10.3390\/vaccines14090793","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:19:16Z","timestamp":1788949156000},"page":"793","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intranasal Adenoviral Vector Vaccination Induces Durable Antibody and T Cell Responses in the Respiratory Tract"],"prefix":"10.3390","volume":"14","author":[{"given":"Woochan","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Advanced Drug Discovery & Development, University of Science and Technology (UST), Daejeon 34113, Republic of Korea"},{"name":"Viral Immunology Laboratory, Institut Pasteur Korea, Seongnam 13488, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Junghwa","family":"Lee","sequence":"additional","affiliation":[{"name":"Viral Immunology Laboratory, Institut Pasteur Korea, Seongnam 13488, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8438-3365","authenticated-orcid":false,"given":"Sun Min","family":"Lee","sequence":"additional","affiliation":[{"name":"Viral Immunology Laboratory, Institut Pasteur Korea, Seongnam 13488, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-5622","authenticated-orcid":false,"given":"Eui Ho","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Advanced Drug Discovery & Development, University of Science and Technology (UST), Daejeon 34113, Republic of Korea"},{"name":"Viral Immunology Laboratory, Institut Pasteur Korea, Seongnam 13488, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"ref_1","first-page":"E64","article-title":"The Spanish Influenza Pandemic: A lesson from history 100 years after 1918","volume":"60","author":"Martini","year":"2019","journal-title":"J. Prev. Med. Hyg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2632010X241228053","DOI":"10.1177\/2632010X241228053","article-title":"The WHO has Declared COVID-19 is No Longer a Pandemic-Level Threat: A Perspective Evaluating Potential Public Health Impacts","volume":"17","author":"Roknuzzaman","year":"2024","journal-title":"Clin. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1440-1843.2009.01554.x","article-title":"Respiratory infections: A current and future threat","volume":"14","author":"Waterer","year":"2009","journal-title":"Respirology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/08998280.2005.11928028","article-title":"Edward Jenner and the history of smallpox and vaccination","volume":"18","author":"Riedel","year":"2005","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ghazy, R.M., Ashmawy, R., Hamdy, N.A., Elhadi, Y.A.M., Reyad, O.A., Elmalawany, D., Almaghraby, A., Shaaban, R., and Taha, S.H.N. (2022). Efficacy and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis. Vaccines, 10.","DOI":"10.3390\/vaccines10030350"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.molmed.2023.01.003","article-title":"Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines","volume":"29","author":"Fraser","year":"2023","journal-title":"Trends Mol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"eadd4853","DOI":"10.1126\/sciimmunol.add4853","article-title":"Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination","volume":"7","author":"Tang","year":"2022","journal-title":"Sci. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMoa2115481","article-title":"Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines","volume":"386","author":"Andrews","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41541-025-01280-0","article-title":"Advances and prospects of respiratory mucosal vaccines: Mechanisms, technologies, and clinical applications","volume":"10","author":"Li","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","article-title":"Tissue-resident memory T cells","volume":"41","author":"Schenkel","year":"2014","journal-title":"Immunity"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e70056","DOI":"10.1002\/mco2.70056","article-title":"Novel vaccine strategies to induce respiratory mucosal immunity: Advances and implications","volume":"6","author":"Zhou","year":"2025","journal-title":"MedComm"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"106119","DOI":"10.1016\/j.ijsu.2021.106119","article-title":"Intranasal COVID-19 vaccines: Is it a boon or bane?","volume":"94","author":"Choudhary","year":"2021","journal-title":"Int. J. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-025-08910-6","article-title":"Nasal vaccines for respiratory infections","volume":"641","author":"Kiyono","year":"2025","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yao, S., Zhai, Z., Liao, L., Zhong, L., Shi, C., Cheng, Y.X., and Liu, X. (2026). Intranasal Vaccine Adjuvants and Delivery Platforms: From Barrier Mechanisms to Clinical Translation. Vaccines, 14.","DOI":"10.3390\/vaccines14040295"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines\u2014Fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1038\/s41598-018-28281-5","article-title":"A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge","volume":"8","author":"Lin","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ontiveros-Padilla, L., Batty, C.J., Hendy, D.A., Pena, E.S., Roque, J.A., Stiepel, R.T., Carlock, M.A., Simpson, S.R., Ross, T.M., and Abraham, S.N. (2023). Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1103765"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Russo, M., Mendes-Correa, M.C., Lins, B.B., Kersten, V., Pernambuco Filho, P.C.A., Martins, T.R., Tozetto-Mendoza, T.R., Vilas Boas, L.S., Gomes, B.M., and Dati, L.M.M. (2023). Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 Infection. Vaccines, 11.","DOI":"10.3390\/vaccines11111732"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100230","DOI":"10.1016\/j.xcrm.2021.100230","article-title":"A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques","volume":"2","author":"Hassan","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-023-06951-3","article-title":"Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques","volume":"626","author":"McMahan","year":"2024","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s41590-024-01951-5","article-title":"Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates","volume":"25","author":"Gagne","year":"2024","journal-title":"Nat. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"112721","DOI":"10.1016\/j.isci.2025.112721","article-title":"Mucosal boosting increases protective efficacy of an influenza vaccine in mice","volume":"28","author":"Wang","year":"2025","journal-title":"iScience"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.celrep.2018.09.029","article-title":"B Cell Competition for Restricted T Cell Help Suppresses Rare-Epitope Responses","volume":"25","author":"Woodruff","year":"2018","journal-title":"Cell Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMc2115596","article-title":"Differential Kinetics of Immune Responses Elicited by COVID-19 Vaccines","volume":"385","author":"Collier","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Kim, D.I., Lee, S.J., Park, S., Kim, P., Lee, S.M., Lee, N., Shum, D., Kim, D.H., and Kim, E.H. (2022). Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19. Vaccines, 10.","DOI":"10.3390\/vaccines10111864"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1513\/pats.200501-003AW","article-title":"T cell memory in the lung airways","volume":"2","author":"Woodland","year":"2005","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1189\/jlb.0313180","article-title":"Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection","volume":"95","author":"Wu","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.cell.2019.04.012","article-title":"Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance","volume":"177","author":"Cirelli","year":"2019","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41586-022-05216-9","article-title":"Long-primed germinal centres with enduring affinity maturation and clonal migration","volume":"609","author":"Lee","year":"2022","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-021-00356-x","article-title":"Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic","volume":"6","author":"Mendonca","year":"2021","journal-title":"npj Vaccines"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2007.10.005","article-title":"Adenovirus vector induced innate immune responses: Impact upon efficacy and toxicity in gene therapy and vaccine applications","volume":"132","author":"Hartman","year":"2008","journal-title":"Virus Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1016\/j.vaccine.2023.04.020","article-title":"Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models","volume":"41","author":"Freitag","year":"2023","journal-title":"Vaccine"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Voronina, D.V., Vavilova, I.V., Zubkova, O.V., Ozharovskaia, T.A., Popova, O., Chugunova, A.S., Goldovskaya, P.P., Zrelkin, D.I., Savina, D.M., and Favorskaya, I.A. (2025). Single-Dose Intranasal or Intramuscular Administration of Simian Adenovirus-Based H1N1 Vaccine Induces a Robust Humoral Response and Complete Protection in Mice. Viruses, 17.","DOI":"10.3390\/v17081085"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41541-025-01186-x","article-title":"Single-dose intranasal adenovirus-based RSV vaccines targeting G and M2","volume":"10","author":"Jang","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Miao, J., Li, X., Li, Y., Mao, L., Suo, W., and Lan, J. (2025). Single-Dose Intranasal Immunization with ChAd68-Vectored Prefusion F Vaccines Confers Sustained Protection Against Respiratory Syncytial Virus in Murine Models. Vaccines, 13.","DOI":"10.3390\/vaccines13050528"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/793\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:30:45Z","timestamp":1788949845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["vaccines14090793"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14090793","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]}}}